Odd Diligence on X
Is $BABA is the only NYSE/Nasdaq listed company that owns Unitree? https://t.co/02u7SwTbOc
Wednesday, August 19
Wednesday, August 19, 2026
Everything we published on this day.
64 stories — the front page that day →
Alpha Metallurgical Resources, Inc. (AMR): The Beginning of the End
Alpha Metallurgical Resources has $263 million of usable liquidity and targets zero cash burn by 2027 through mine cuts, Wildcat ramp-up,…
Colin King on X
$FOUR Wrote about this one recently… seems like an interesting roll-up with a story that’s getting less complex (former Up-C structure) https://t.co/CV5VPUekSL https://t.co/llyNFPKqsD
Research Roundup Vol. XLIX
Research Roundup Vol. XLIX covers 3.4% inflation, AI compute demand, data center buildouts, and Q2 reports from Rocket Lab, CoreWeave,…
💥DISH to Trinseo, “Hold My Beer”💥
EchoStar’s DISH DBS and DISH Wireless prepackaged bankruptcy cases receive an update a month after coverage began.
Maius on X
Humanoids down under! While it may surprise, Appen $APX.AX used to be the world's largest data labeling company, but it lost market share to $INOD because it was slow to adapt its tech stack and lacked product-market fit. However, their Chinese business (China's largest) continues to do well and has really seen an inflection; all the forward hiring trends we see are extremely strong. So if you believe Chinese AI and robots have any relevance globally, they should benefit. Yours truly for sub-1x revenues, because most Australian investors still have this stock on a blacklist after losing their shirt last cycle.
The Navy’s Best Kept $180M Secret
Espey Mfg. & Electronics, ESP, supplies sole-source power systems for Navy Virginia and Columbia submarines, retaining fixed-price…
Odd Lot Arbitrageur on X
I like $PFHO https://t.co/SR8jMdKVlW
KEDM.com on X
Quite a few directors at Bath & Body Works $BBWI are buying the dip on poor earnings, with the shares dropping to multi-year lows. With negative sentiment pressuring the topline and margins and quite a bit of leverage, we’re not surprised to see this share price action. That said, the company is refocusing on key franchises, improving its product offering, and cutting costs heavily. It's too early to touch this one, but it's certainly interesting to keep on the watchlist on a potential inflection of the fundamentals (while the market continues to puke the shares).
Pernas Research on X
Nothing decays faster than borrowed conviction…… $CEPL melt up then sell off https://t.co/yD9uwh2wdD
Pernas Research on X
I forget who tweeted this about a year ago, but they used $NKE as a great example of a low-volatility, blue-chip stock that was risky. They deserve credit. Low volatility and blue chip do not mean low risk. https://t.co/RhNJPBUlJM
Evan Tindell on X
Hi please bring me all of your most bearish arguments on $MRNA and why this price is unsustainable, the final phase 3 data won't be that good, it won't work in other cancers, etc
Deep Sail Capital on X
@stockgutter @paulcerro I see 18% borrow rate on $MRNX . Was up 353% today. Wow.
Myles on X
@FriendlyCapMgmt Am short both. Though I feel like they were a bit more mainstream especially $EOSE. I'd put stuff like $ABXX, $MRDN, $FNGR into the bucket.
Cluseau Investments on X
If you buy the $SNDK Dec 2028 1560 Straddle the stock would have to drop below $30 to make money on the downside
kab60 on X
$JKHY: "We delivered a record 58 competitive core wins for the year, including 14 institutions with more than $1B in assets, and both fourth-quarter and full-year non-GAAP revenue reached new highs." WONDER WHO THEY WON THOSE FROM $FISV https://t.co/60Z4Tv8OCK
kab60 on X
The way mkt values $FIS vs $JKHY is as if it's $AAP vs. $ORLY / $AZO. Wait to see what happens when mkt realizes it's a StiCKY, mIsSiOn CriTiCaL sYStEm oF reCoRD cOmPounDiNG FCF/SHARE > 15%!!! #NEVERSELL
kab60 on X
@BillRoman15 Yes, I broadly agree. $ABG and $LAD went big on M&A, now switched to buybacks. $GPI was more flexible, now a pretty sizeable deal. $AN and $SAH both with failed used dealership investments. As for $AN, you mean buying CIG Financial to launch their own DFC initiative?
kab60 on X
@BillRoman15 It looks rich vs. the stock today, but I think $GPI mngmt has done a great job clustering stores and balancing M&A with buybacks. Don't agree on empire building - they divested stores worth almost 400m in H1.
kab60 on X
@B_Archibald I think that's a personal thing. I don't mind having 25-30% in a single sector, so I'm >20% in $GPI and $ABG currently. I find them easy to average down into given how resilient they are + few Q's around terminal value (imo), but again, miles vary (widely).
kab60 on X
I'm fishing but also tend to be early! At 6x earnings for the best store footprint+brand mix, $GPI looks dirt cheap to me. As does $ABG after change of CEO and change in capital allocation. $PAG launching a take-private & $LAD & $ABG hitting buybacks suggest ok outlook. https://t.co/nKPTwKHuDY
kab60 on X
Anyone seen any transcripts from JPM Automotive? $GPI $ABG or other dealership notes?
Trevor Scott on X
@ValueStockGeek @TSOH_Investing $UAA is a classic example https://t.co/l07hYqHs9w
Charles Frischer on X
$KWY I have attached my notes on Kingsway. I think the company is at an inflection point based upon the excellent quarter they just announced. Very excited to see how the next few years play out for shareholders. I am optimistic. $10 per share should be an excellent entry point. https://t.co/j0rgEf3hUR
Charles Frischer on X
@Jono8325 @MLedrappier @roadkillrecipes @CalgaryLeveen @FishOnCapital $NN Someone asked my opinion. I provided it. I am sorry if it makes you frustrated that things often take longer than we expect. It has been my life experience that things take longer than expected. That said, I am very positive on the next couple of months with NN.
PAA Research on X
The question needs to be asked: Why haven't $META and $GOOG done more to control the narrative around data center construction? They literally can amplify whatever news, posts, and videos they want. We've learned that. Don't tell me they've learned their lesson about meddling (there's a $1T+ court case ongoing that tells me otherwise). Instead we're hearing narratives about China and Tiktok, when two MAJOR AI players own the pipes that serve every other social media post and video in this country. It's a strange set of circumstances. Would $GOOG and $META benefit if @AnthropicAI and @openAI go through the windshield? Of course, but it's not obvious how a backlash against data centers helps these hyperscalers otherwise. Thoughts?
SG on X
@DeepSailCapital @paulcerro There is also a 2x ETF $MRNX that has a reasonable rate but I don't currently see a borrow.
SG on X
$MRNA any basis to think this can make it as a monotherapy or just combination drug?
SG on X
Good report from $BULL. I remain long and may add. https://t.co/mvOiOAN83t
SG on X
$ADMQ ceo buying more. He owns just under 40% and adds often but in small increments. https://t.co/B0ZWI30u9y
SG on X
Covered my short of $AZ today at a slight loss. I still am skeptical but have to admit that the company has been executing better the last two quarters.
SG on X
surprised to see the dip in $CCXI (SPAC to acquire Agility Robotics) today following the huge interest in Unitree IPO. https://t.co/wo7Hx1xVQL
SG on X
$MRNA news could be a huge breakthrough (probably will take years to know one way or the other), or it could be something not replicated in other trials. Either way the move is just enormous and the likelihood of a raise in the next few months is very high imo. Selling a few Jan27 220 calls, priced around 22.
Maj Soueidan on X
I used to like $EML, but it was never able to sustain the momentum it was gaining prior to COVID, partly due to its exposure to the cyclical trucking market. It's recent acquisitions in the aerospace could make it interesting again. https://t.co/u7uvBGERlA
Broken Moats on X
$mrna secondary coming in 21.05 minutes
Broken Moats on X
Continue to believe that expiration this week will be the culmination in the software squeeze. Money will want to come off the table ahead of earnings season for the sector, and I think that will be followed with an acknowledgment from earnings that while their revenues are not at risk today - these companies still do face increased competition, lower barriers, higher costs for cloud/inference, and seat based model problems that will be challenging moving forward. The $WDAY rumor news was not the floor, it was the peak counter narrative to AI disruption.
Broken Moats on X
Impressive just how many healthcare companies with no direct or derivative exposure today or at any point to the $MRNA news can rally 10%+ on the day. Be smart for these companies to pocket these gains with secondaries and solidify fragile balance sheets, but in the ultimate short term pump market their management teams will no doubt not want to interrupt their stocks squeeze potential and will not issue shares, but aggressively unload their options
junkbondinvestor on X
NEBIUS GROUP TO OFFER $4.5 BILLION OF CONVERTIBLE SENIOR NOTES Wow, that's a monster convert issuance. But when your stock is this volatile, that vol is an asset. $NBIS https://t.co/B3VKZw72rx
APP 2026-08-19 AppLovin: Here's How I See 3 Catalysts That Could Drive Valuation Re-Rating
AppLovin’s AXON 2.0 self-serve rollout, e-commerce onboarding and Connected TV expansion aim to revive growth after Q2 2026 revenue and…
KL Research 2 clicks AZN 2026-08-19 AstraZeneca Vs. Bristol-Myers Squibb: Who's The Better Bargain For Investors?
AstraZeneca and Bristol-Myers Squibb are compared on oncology and inflammatory-disease drug portfolios as merger rumors cool.
PGY 2026-08-19 Pagaya Technologies: A Fast-Growing Industry Disruptor Trading At A P/E Of 6.6x
Pagaya Technologies reported Q2 2026 network volume of $3.54 billion, 19% revenue growth and 99% adjusted net-income growth, while trading…
Akim Guerreiro CRWV 2026-08-19 CoreWeave: The Execution Story Is Flashing A Strong Signal (Rating Upgrade)
CoreWeave’s Q2 converted backlog into sales, expanded margins and lifted operating leverage as active contracts topped half of its $104.2…
Future Stack Investment 1 click RDDT 2026-08-19 Reddit: Curb Your Enthusiasm About The Index Effect
Reddit joins the S&P 500 on August 18 after a short-term rally, while Q2 revenue growth came from ad pricing rather than user expansion and…
Dilantha De Silva 1 click ZETA 2026-08-19 Zeta Global's AI Story Just Became Measurable (Rating Downgrade)
Zeta Global’s Athena AI superusers grow four times faster, while comprehensive adopters generate 70% of revenue.
Alpha Line 1 click QNT 2026-08-19 Quantinuum: Trapped-Ion Quantum Computing Looks To Break Out Of The Quantum Silo
Quantinuum, newly public after its June 3, 2026 IPO, pitches trapped-ion accuracy, full-stack quantum tools and an Oracle deal linking…
Marc Gerstein Timyan Bank Alert on X
QNB Corp. $QNBC Announces Pricing of Common Stock Offering https://t.co/5mPLeT0iSH
BDC on X
@DueDoctor Oh I agree 100%. The move is totally insane. $GME like. +20% would have made some sense based on math. I actually think lack of 2ndary here is even WORSE for them. They need the cash. 2ndary cleans up that need.
BDC on X
@DueDoctor All goes well this could add $800mn in annual revenue to $mrna. Added $44B in market cap. Market said that theoretical 2-3 year out revenue is worth 50x + yesterdays' market cap
NCLH or her grandma Saga?
Norwegian Cruise Line’s $15 billion debt and 2026-27 capex delay deleveraging, despite fuel-efficient new ships and stronger projected 2028…
Mike on X
@mathlonning $SIF especially, I thought the Q was good
BDC on X
@BoxLongs $SNAP added $250mn in revenue yy and $200mn in adj ebitda. Adj shares outstanding actually decreased 70 bps yy. FCF +400% yy. While everyone knows its a horribly managed asset, the numbers in isolation are MUCH improved YoY while stock itself is down 30% yy.
Ian Bezek on X
@SandBrandyn I bought a basket of software and adjacent in Feb/March. $TEAM most ridiculous example both to the down and now upside... I don't trust the management teams enough to make a concentrated bet on any of these.
Ian Bezek on X
Atlassian $TEAM now up 214% since April, and +5% YTD. Market very efficiently determining future discounted cash flows from software companies, I see.
Ian Bezek on X
@LocalHero55 @OtterMarket @gatorcapital Post on an even more obscure MHC bank. And yes, $TFSL is a great income instrument, with (eventually) a chunky cap gain exit when they finally convert.
mavix on X
I just published the Earnings Update about the Q2 2026 results of Leatt $LEAT. You can find it in the Portfolio section of the blog :) https://t.co/HSSFsXmH3R
Ian Bezek on X
@OtterMarket @gatorcapital $tfsl is just under a billion when you exclude the phantom shares. I've owned it a long time and very few people care about it either. That said, this NY one is even more obscure
Ian Bezek on X
@stoked_on_waves @CapitalShipyard $open's backers also claim it is profitable. Apparently you can just say stuff now
BDC on X
Could happen. Also - there will be a massive 2ndary soon and insiders will start dumping shares. I wish this was a cure for cancer. It is not. If it ever even commercializes (still a big if) it will be just another thearaputic that will be sold along with Keytruda and in some cases may deter relapse. That's it. In fact, we may learn that the same lipid nano particles that the mrna technology relies on and which have been speculated to be a cancer causer in their own right (hint, they are) actually cause occurence of other cancers such as colon and pancreatic and breast. Does lowering recurrence in melanoma in exchange for a higher chance of colon cancer sound like a "cure"? I wish it was. No material position as of now. Congrats to bulls, I guess. $MRNA
Airbnb Model Update (2026)
Airbnb shares have risen about 50% since October 2025, prompting a revised 2026 model and return assumptions at the current price.
BDC on X
This is really bullish $STLN. Their data underpins much of the potential here in oncology immunotherapies. https://t.co/mimQBZ9OM2
JabroniCoin.USD on X
Steadily down, then suddenly. H/T @forgebitz Semrush showed signficant decline for $RDDT citations last year, and now a sudden further plummet. Perhaps human shitposting and SEO AI slop fest isn’t indispensable data… https://t.co/aSIBSTBUfE https://t.co/z0EEAvAm7E
BDC on X
Reality check: Ph2 $MRNA lead with the data. Ph3, no actual data. They are just saying they hit their endpoints. Those being RFS, DFMS, OS. "We have not disclosed with Merk kind of where the goalpost is". This is not a "personalized cancer vaccine". $MRNA gave themselves an A on the test but we don't know how hard the test was. That's what this is.
mavix on X
Shelly Group $SLYG has entered into a pan-European partnership with ALSO, Europe’s largest technology provider that provides an extensive network of resellers, system integrators and professional installers. It also supports Shelly’s international scaling strategy. https://t.co/E4Gg0SWhIA
mavix on X
Shelly Group $SLYG major shareholder Svetlin Todorov has transferred nearly 1/4 of his shares (6.5% of Shelly) into a LLC he also owns. Maybe a preparation for a potential partial sale to Schneider Electric who would buy into Shelly as a strategic investor / partnership? https://t.co/YJfHzbSeeH
